EST Cathie Wood’s ARK Investment bought 147K shares of Crispr Therapeutics (CRSP) todayStay Ahead of the Market:Discover outperforming ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Rare Disease Day is recognized every 28th (or sometimes 29th) day of February, and there are approximately 30 million reasons ...

Dennison also describes how CRISPR screening tools will be key to further ... I think the reason is that the clinical team is relatively small, so they can buy into the project. We've got good links ...

Analysts with Needham say Instacart stock is a buy, as the firm is growing despite competition from Uber, Amazon and others.

When you buy through our links ... suction for your fingers and toes to prevent slippage and is especially good for hot yoga. But it has a strong odor that takes a while to dissipate.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

As long as the index holds above 23,890, a buy-on-dips strategy is advisable for Nifty," commented Hrishikesh Yedve, AVP Technical and Derivatives Research at Asit C. Mehta Investment ...